HCA Proceeds to Support General Corporate Purposes and Potential Redemption of 2026 Senior Notes
HCA Healthcare, Inc. today announced that its wholly owned subsidiary, HCA Inc., proposes to offer senior notes, subject to market and other considerations. Actual terms of the senior notes, including maturity, interest rate and principal amount, will depend on market conditions at the time of pricing. HCA Inc. intends to use the net proceeds from this offering for general corporate purposes, which may include the repayment of outstanding borrowings under its $4.000 billion commercial paper program (which may be reborrowed from time to time), and may use a portion of the net proceeds from this offering for the redemption of all or a portion of the $1.500 billion outstanding aggregate principal amount of its 5.875% senior notes due 2026.
J.P. Morgan Securities LLC, Citigroup Global Markets Inc., Mizuho Securities USA LLC and Wells Fargo Securities, LLC are acting as the joint book-running managers for the offering.
The offering of the senior notes is being made pursuant to an effective shelf registration statement filed with the Securities and Exchange Commission. The offering is being made only by means of a preliminary prospectus supplement and the accompanying prospectus, copies of which may be obtained by contacting J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717 or by email at prospectus-eq_fi@jpmchase.com and postsalemanualrequests@broadridge.com; Citigroup Global Markets Inc., c/o Broadridge Financial Solutions,
1155 Long Island Avenue, Edgewood, NY 11717, by telephone: 1-800-831-9146 or by email: prospectus@citi.com; Mizuho Securities USA LLC, Attn: Debt Capital Markets, 1271 Avenue of the Americas, New York, New York 10020, or by calling toll-free at 1-866-271-7403; or Wells Fargo Securities, LLC, 608 2nd Avenue South, Suite 1000, Minneapolis, MN 55402, Attn: WFS Customer Service, by email: wfscustomerservice@wellsfargo.com or by telephone (toll-free): 1-800-645-3751.
You may also visit www.sec.gov to obtain an electronic copy of the related preliminary prospectus supplement and the accompanying prospectus.
This press release does not constitute an offer to sell or a solicitation of an offer to buy the senior notes or any other security or a notice of redemption of any 5.875% senior notes due 2026 and shall not constitute an offer, solicitation or sale in any state or jurisdiction in which, or to any persons to whom, such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. Any notice of redemption of the 5.875% senior notes due 2026 will be made pursuant to a separately issued notice of redemption.
HCA Healthcare, Inc. (NYSE: HCA) announced that its wholly owned subsidiary, HCA Inc., plans to offer senior notes, subject to market and other conditions. The terms of the offering, including maturity, interest rate, and principal amount, will be determined based on prevailing market conditions at the time of pricing.
HCA Inc. intends to use the net proceeds from the offering for general corporate purposes, which may include repaying borrowings under its $4.0 billion commercial paper program and potentially redeeming all or a portion of its $1.5 billion outstanding 5.875% senior notes due 2026. J.P. Morgan Securities LLC, Citigroup Global Markets Inc., Mizuho Securities USA LLC, and Wells Fargo Securities, LLC will serve as joint book-running managers for the offering, which will be made under an effective shelf registration statement filed with the SEC.
HCA Healthcare, Inc. (NYSE: HCA) today announced that its wholly owned subsidiary, HCA Inc., intends to offer senior notes, subject to market and other conditions. The final terms, including maturity, interest rate, and principal amount, will be determined at the time of pricing.
Source link: https://investor.hcahealthcare.com/
